Sherbrooke team patents GlioTrap brain cancer treatment after promising preclinical cures Sherbrooke researchers patent GlioTrap, a gel-based brain cancer treatment showing strong preclinical results; the team aims to begin human …
The Calgary Tribune @2021 All rights reserved.